Global Liver Cancer Treatment Market Poised for Breakthrough Growth Driven by Innovative Therapies and Expanding Patient Access 2025 | DataM Intelligence

Market Size and Growth:

The Global Liver Cancer Treatment Market size reached US$ 4.58 billion in 2024 and is expected to reach US$ 12.88 billion by 2033, growing at a CAGR of 11.4% during the forecast period 2025-2033.

Liver Cancer Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/liver-cancer-treatment-market?sz

The Liver Cancer Treatment Market encompasses therapies, drugs, and medical procedures aimed at diagnosing, managing, and curing liver cancer. It includes surgical interventions, targeted therapies, immunotherapy, chemotherapy, and radiation treatments. This market is driven by advancements in medical technology, rising liver cancer prevalence, improved diagnostics, and growing demand for personalized treatment approaches to enhance patient outcomes.

Industry News of USA and Japan:

United States:

HistoSonics Valued at US$ 2.25 B:
A majority stake in HistoSonics developer of an FDA-cleared, noninvasive liver tumor treatment using focused ultrasound ("histotripsy") was acquired by investors led by K5 Global, bringing the company's valuation to $2.25 billion as of August 2025.

FDA Approves Nivolumab + Ipilimumab Combo as First-Line HCC Therapy:
In April 2025, the FDA approved the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) as a first-line treatment for adult patients with unresectable or metastatic hepatocellular carcinoma (HCC).

Japan:

Takeda Launches LIVMARLI Oral Solution
In June 2025, Takeda Pharmaceuticals launched LIVMARLI Oral Solution 10 mg/mL in Japan, aimed at treating pruritus associated with cholestasis in Alagille syndrome and progressive familial intrahepatic cholestasis conditions tied to liver dysfunctions

Terumo Unveils Occlusafe & LifePearl Therapy Devices
In November 2023, Terumo Corporation (Japan) introduced two new medical devices Occlusafe and LifePearl designed to enhance the precision and efficacy of transcatheter arterial chemoembolization (TACE) for managing hepatocellular carcinoma (HCC).

Key Players:

Eli Lilly and Company
AstraZeneca
Eisai Inc.
TAIHO ONCOLOGY, INC.
Bayer AG
Bristol-Myers Squibb Company.
Incyte.
Genentech USA, Inc.
Exelixis, Inc.
Merck & Co., Inc.

Growth Forecast Projected:

The Global Liver Cancer Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Liver Cancer Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=liver-cancer-treatment-market

Market Segmentation:

By Cancer Type: Hepatocellular Carcinoma, Cholangiocarcinoma, Others.

By Treatment Type: Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, Surgery, Ablation and Embolization Therapies, Others.

By Route of Administration: Injectable, Oral.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/liver-cancer-treatment-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Liver Cancer Treatment market?

➠ Who are the leading manufacturers in the global Liver Cancer Treatment industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Liver Cancer Treatment industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Liver Cancer Treatment market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.